삼성서울병원

Ko En

피부과 이주흥 교수

진료분야
건선, 여드름, 혈관종, 화염상모반
진료일정 01 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 02 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
오전
오후

학력

학력
1996.02 서울대학교 의과대학 의학박사
1990.02 서울대학교 의과대학 의학석사
1986.02 서울대학교 의과대학 의학사

경력

경력
2022.01 ~현재 성균관대학교 의과대학 학장
2009.01 ~현재 삼성서울병원 임상시험윤리위원회(IRB) - 위원장 (D)
2008.04 ~현재 성균관의대/삼성서울병원 피부과 - 교수
2005.03 ~현재 삼성서울병원 임상시험윤리위원회(IRB) - 위원
2016.01 ~ 2021.10 삼성서울병원 교육인재개발실장
2009.10 ~ 2017.03 성균관대학교 피부과학교실 주임교수
2009.10 ~ 2017.03 삼성서울병원 피부과장
2006.05 ~ 2016.01 삼성서울병원 피부레이저치료실 - 실장
2013.08 ~ 2015.07 삼성서울병원 교육수련부 부장
2007.09 ~ 2013.07 삼성서울병원 교육수련부 차장
2007.03 ~ 2011.02 성균관대학교 의과대학 교육담당 부학장보
2002.03 ~ 2008.03 성균관의대/삼성서울병원 피부과 - 부교수
2001.03 ~ 2002.02 성균관의대/삼성서울병원 피부과 - 임상부교수
1993.05 ~ 2000.10 인하대학교/인하대학교병원 피부과 - 전임강사/조교수
1998.07 ~ 2000.03 University of Michigan, Ann Arbor - visiting fellow
1990.03 ~ 1993.04 육군 군의관
1987.03 ~ 1990.02 서울대학교병원 - 전공의 (피부과)
1986.03 ~ 1987.02 서울대학교병원 - 수련의

연구분야

연구분야
건선의 치료 방법 및 치료제에 대한 연구
건선은 피부 면역기능의 이상과 피부 세포의 지나친 증식으로 인해 홍반과 인설을 동반한 구진과 두꺼운 판이 발생하는 질환입 니다. 대부분 만성으로 지속되며 자주 재발하는 피부질환입니다. 건선은 당뇨병이나 고혈압과 같이 `조절하며 사는 질환` 이라고 생각하셔야 합니다. 만성질환이고 재발을 반복하므로 치료에 동반되는 부작용을 예방하기 위해 순환요법, 순차요법, 병행요법 등의 다양한 치료 방법을 적용하는 것이 필요합니다. 최신 자외선 치료 장비는 물론 최근 개발된 면역 치료제의 국제 공동 임상시험등을 통해 가장 앞선 치료법 연구를 진행하고 있습니다. 이와 같은 지속적인 임상연구와 기초연구가 매우 중요합니다.

학회활동

학회활동
1994.01 ~ 현재 American Academy of Dermatology - International fellow
1990.03 ~ 현재 대한피부과학회 - 정회원
2011.10 ~ 2015.12 대한피부과학회 학술이사(연임)
2011.09 ~ 2015.09 대한건선학회 회장(연임)
2012.11 ~ 2014.11 대한화장품의학회 총무이사
2010.03 ~ 2012.02 대한여드름학회 재무이사
2009.10 ~ 2011.09 대한피부과학회 보험이사
2007.05 ~ 2011.04 대한건선학회 - 총무이사
2008.03 ~ 2010.02 대한여드름학회 - 기획이사
2006.03 ~ 2008.02 대한여드름연구회 - 학술이사
2003.05 ~ 2007.04 대한건선학회 - 학술이사 (연임)
2002.07 ~ 2004.06 대한코스메틱피부과학회 - 교육이사
2001.05 ~ 2003.04 대한건선학회 - 간행이사
  • J DERMATOL 2020 10.1111/1346-8138.15733 Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis A randomized, phase III, double-blind, placebo-controlled study Seo1, SJ; Shin, BS; Lee, JH; Jeong, H
    View PubMed
  • DERMATOLOGY 2020 10.1159/000511623 Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption Park1, JH; Choi, Y; Kim, HJ; Oh, SJ; Lee, DY; Lee, JH; Lee, JH
    View PubMed
  • J DERMATOL 2019 10.1111/1346-8138.15004 Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study Lee1, MG; Huang, YH; Lee, JH; Lee, SC; Kim, TG; Aw, DCW; Bao, WB; Dee, CMA; Guana, A; Tsai, TF
    View PubMed
  • ANN DERMATOL 2019 10.5021/ad.2019.31.3.345 A Case of Nivolumab-Induced Lichen Planus Oh1, SJ; Choi, YH; Byun, HJ; Oh, SH; Park, JH; Lee, JH; Lee, DY; Lee, JH; Yang, JM
    View PubMed
  • ANN DERMATOL 2019 10.5021/ad.2019.31.3.361 Chronic Exfoliative Cheilitis Successfully Treated by Pinhole Method Using CO2 Laser Park1, CS; Park, JH; Lee, J; Byun, HJ; Lim, Y; Lee, JH; Lee, DY; Lee, JH; Yang, JM
    View PubMed
  • ANN DERMATOL 2019 10.5021/ad.2019.31.2.235 A Case of Unusual Juvenile Xanthogranuloma on the Subungual Area Park1, CS; Lee, DY; Lee, JH; Lim, Y; Park, JH; Lee, JH; Lee, JH; Yang, JM
    View PubMed
  • ANN DERMATOL 2019 10.5021/ad.2019.31.1.29 Usefulness of the Psoriatic Arthritis Screening and Evaluation Questionnaire to Monitor Disease Activity in Management of Patients with Psoriasis: Findings from the EPI-PSODE Study Choe1, YB; Park, CJ; Yu, DY; Kim, Y; Ju, HJ; Youn, SW; Lee, JH; Kim, BS; Seo, SJ; Yun, SK; Park, J; Kim, NI; Youn, JI; Lee, SJ; Lee, MG; Kim, KJ; Ro, YS; Song, HJ; Shin, BS; Ahn, SK; Lee, JY; Won, YH; Jang, MS; Kim, KH; Kim, MH; Kim, TY; Choi, JH
    View PubMed
  • J EUR ACAD DERMATOL 2018 10.1111/jdv.14865 The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study) Youn1, SW; Lee, JH; Yu, DY; Kim, Y; Kim, BS; Seo, SJ; Choe, YB; Yun, SK; Park, J; Kim, NI; Choi, CW; Youn, JI; Lee, SJ; Lee, MG; Kim, KJ; Park, CJ; Ro, YS; Song, HJ; Shin, BS; Ahn, SK; Lee, JY; Won, YH; Jang, MS; Kim, KH; Kim, MH; Kim, TY; Choi, JH
    View PubMed
  • EUR J DERMATOL 2018 10.1684/ejd.2018.3341 Factors influencing quality of life in patients with psoriasis in Korea Lee1, JH; Lee, SM; Choi, JH; Park, CJ; Kim, BS; Shin, BS; Park, HJ; Kim, NI; Kim, KJ; Shin, A; Suh, D; Jun, J; Chang, Y; Suh, DC
    View PubMed
  • ANN DERMATOL 2018 10.5021/ad.2018.30.4.451 Olmutinib Induced Lichen Planus Like Eruption Oh1, SH; Byun, HJ; Oh, SJ; Jun, JY; Park, JH; Lee, JH; Lee, DY; Lee, JH; Yang, JM
    View PubMed
  • ANN DERMATOL 2017 10.5021/ad.2017.29.4.462 The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE) Song1, HJ; Park, CJ; Kim, TY; Choe, YB; Lee, SJ; Kim, NI; Cho, JW; Jeon, JH; Jang, MS; Youn, JI; Kim, MH; Park, J; Kim, KH; Kim, BS; Youn, SW; Lee, JH; Lee, MG; Ahn, SK; Won, YH; Yun, SK; Shin, BS; Seo, SJ; Lee, JY; Kim, KJ; Ro, YS; Kim, Y; Yu, DY; Choi, JH
    View PubMed
  • J Dermatolog Treat. 2016 Aug;27(4):373-7. doi: 10.3109/09546634.2015.1115812. Epub 2015 Dec 4. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study Chung JY11, Lee JH1,2, Lee JH1.
    View PubMed
  • J Eur Acad Dermatol Venereol. 2016 Feb;30(2):276-81. doi: 10.1111/jdv.13472. Epub 2015 Nov 13. Moisturizers are effective in the treatment of xerosis irrespectively from their particular formulation: results from a prospective, randomized, double-blind controlled trial Shim JH11, Park JH1, Lee JH1,2, Lee DY1, Lee JH1, Yang JM1.
    View PubMed
  • Ann Dermatol. 2015 Dec;27(6):727-37. doi: 10.5021/ad.2015.27.6.727. Epub 2015 Dec 7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Analysis of Clinicopathological Feature and Treatment Outcome of Seven Cases Kim JH11, Park HY1, Lee JH1, Lee DY1, Lee JH1, Yang JM1.
    View PubMed
  • Lancet.?2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial Bachelez H1,?van de Kerkhof PC,?Strohal R,?Kubanov A,?Valenzuela F,?Lee JH,?Yakusevich V,?Chimenti S,?Papacharalambous J,?Proulx J,?Gupta P,?Tan H,Tawadrous M,?Valdez H,?Wolk R;?OPT Compare Investigators.
    View PubMed
  • Clin Exp Dermatol. 2015 Jul;40(5):479-84. doi: 10.1111/ced.12593. Epub 2015 Feb 16. Comparison of diagnostic methods for onychomycosis, and proposal of a diagnostic algorithm Jung MY11, Shim JH1, Lee JH1, Lee JH1, Yang JM1, Lee DY1, Jang KT2, Lee NY3, Lee JH3, Park JH4, Park KK5.
    View PubMed
  • J Dermatolog Treat. 2015 Jun;26(3):246-51. doi: 10.3109/09546634.2014.933163. Epub 2014 Jul 9. Photodynamic therapy using a new formulation of 5-aminolevulinic acid for wrinkles in Asian skin: A randomized controlled split face study Shin HT11, Kim JH, Shim J, Lee JH, Lee DY, Lee JH, Yang JM.
    View PubMed
  • Ann Dermatol. 2015 Apr;27(2):220-1. doi: 10.5021/ad.2015.27.2.220. Epub 2015 Mar 24. A Case of Cutaneous Metastatic Cholangiocarcinoma on the Percutaneous Transhepatic Biliary Drainage Catheter Insertion Site Lee JH11, Lee YJ1, Chung JY1, Jung MY1, Park JH1, Lee JH1, Lee JH1, Yang JM1, Lee DY1.
    View PubMed
  • Ann Dermatol. 2015 Apr;27(2):184-9. doi: 10.5021/ad.2015.27.2.184. Epub 2015 Mar 24. Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report Youn SW11, Kim BR1, Lee JH2, Song HJ3, Choe YB4, Choi JH5, Kim NI6, Kim KJ7, Youn JI8.
    View PubMed
  • Am J Hum Genet. 2015 Feb 5;96(2):266-74. doi: 10.1016/j.ajhg.2014.11.019. Epub 2015 Jan 22. Mutations in DDX58, which Encodes RIG-I, Cause Atypical Singleton-Merten Syndrome Jang MA11, Kim EK2, Now H3, Nguyen NT3, Kim WJ3, Yoo JY3, Lee J4, Jeong YM5, Kim CH5, Kim OH6, Sohn S7, Nam SH8, Hong Y8, Lee YS8, Chang SA2, Jang SY2, Kim JW1, Lee MS9, Lim SY10, Sung KS11, Park KT12, Kim BJ13, Lee JH14, Kim DK2, Kee C15, Ki CS16.
    View PubMed
  • Ann Dermatol. 2014 Dec;26(6):783-5. doi: 10.5021/ad.2014.26.6.783. Epub 2014 Nov 26. A Case of Reticulate Acropigmentation of Kitamura Treated with 532-nm Q-Switched Nd:YAG Laser: 10 Years of Follow-Up Observation Lee JH11, Lee JH1, Lee JH1.
    View PubMed
  • J Dermatolog Treat. 2014 Aug;25(4):326-30. doi: 10.3109/09546634.2013.769041. Epub 2013 Jun 2. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A Lee JH11, Park JH, Lee SK, Han KH, Kim SD, Yoon CS, Park JY, Lee JH, Yang JM, Lee JH.
    View PubMed
  • J Dermatol. 2014 Apr;41(4):292-5. doi: 10.1111/1346-8138.12332. Epub 2014 Feb 24. Treatment of ingrown nail with a special device composed of shape-memory alloy Park SW11, Park JH, Lee JH, Lee DY, Lee JH, Yang JM.
    View PubMed
  • Ann Dermatol. 2014 Feb;26(1):92-5. doi: 10.5021/ad.2014.26.1.92. Epub 2014 Feb 17. Cutaneous Mycobacterium massiliense Infection of the Sole of the Feet Jung MY11, Lee JH1, Kim CR1, Kim HJ1, Koh WJ1, Ki CS2, Lee JH1, Yang JM1, Lee DY1.
    View PubMed
  • Ann Dermatol. 2014 Feb;26(1):61-5. doi: 10.5021/ad.2014.26.1.61. Epub 2014 Feb 17. Clinical Course of Segmental Vitiligo: A Retrospective Study of Eighty-Seven Patients Park JH11, Jung MY2, Lee JH2, Yang JM2, Lee DY2, Park KK3.
    View PubMed
  • Ann Dermatol. 2014 Feb;26(1):123-4. doi: 10.5021/ad.2014.26.1.123. Epub 2014 Feb 17. Superficial Acral Fibromyxoma on the Palm Park SW11, Kim JH1, Shin HT1, Park JH1, Lee JH1, Lee DY1, Lee JH1, Yang JM1.
    View PubMed
  • J Drugs Dermatol. 2012 Aug;11(8):943-9. Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial Tsai TF11, Song M, Shen YK, Schenkel B, Choe YB, Kim NI, Lee JH, Lee JH, Song HJ, Youn JI; PEARL investigators.
    View PubMed
  • Acta Derm Venereol. 2012 May;92(3):236-40. doi: 10.2340/00015555-1331. A Nationwide Study of Acne Treatment Patterns in Korea: Analysis of Patient Preconceived Notions and Dermatologist Suggestion for Treatment Kwon HH11, Yoon HS, Suh DH, Yoon JY, Park SK, Lee ES, Lee JH, Kim NI, Kye YC, Ro YS, Lee SJ, Kim MN, Sung KJ, Lee ES, Kim KJ; Korean Society for Acne Research.
    View PubMed
  • Br J Dermatol. 2011 Jul;165(1):171-6. doi: 10.1111/j.1365-2133.2011.10269.x. Ortonne JP11, Nikkels AF, Reich K, Ponce Olivera RM, Lee JH, Kerrouche N, Sidou F, Faergemann J.
    View PubMed
  • Ann Dermatol.?2011 May;23(2):254-7. doi: 10.5021/ad.2011.23.2.254. Epub 2011 May 27. Subcutaneous Dermatofibroma Jung KD11,?Lee DY,?Lee JH,?Yang JM,?Lee ES.
    View PubMed
  • 없음 A case of Paederus dermatitis
  • J Cosmet Laser Ther. 2015 Jun 14:1-20. [Epub ahead of print] The treatment of syringomas by CO2 laser using a multiple-drilling method Seo HM1, Choi JY, Min J, Kim WS.
    View PubMed
  • Clin Exp Dermatol. 2006 Jan;31(1):83-5. Aggressive NK-cell leukaemia associated with reactive haemophagocytic syndrome Choi YL11, Park JH, Kim WS, Lee DY, Lee JH, Yang JM, Lee ES.
    View PubMed
  • Clin Exp Dermatol.?2005 Nov;30(6):733-4. Multiple skin-coloured papules in a child Park HS11,?Kim MG,?Youn SJ,?Kim WS,?Lee DY,?Lee JH,?Yang JM,?Lee ES.
    View PubMed
  • J Invest Dermatol. 2002 Aug;119(2):507-12. Ultraviolet modulation of human macrophage metalloelastase in human skin in vivo Chung JH11, Seo JY, Lee MK, Eun HC, Lee JH, Kang S, Fisher GJ, Voorhees JJ.
    View PubMed